- Home
- TNGX vs SLI Comparison
TNGX vs SLI Comparison
Compare TNGX & SLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNGX
- SLI
- Stock Information
- Founded
- TNGX 2014
- SLI 1998
- Country
- TNGX United States
- SLI Canada
- Employees
- TNGX N/A
- SLI N/A
- Industry
- TNGX Biotechnology: Pharmaceutical Preparations
- SLI Major Chemicals
- Sector
- TNGX Health Care
- SLI Industrials
- Exchange
- TNGX Nasdaq
- SLI Nasdaq
- Market Cap
- TNGX 723.2M
- SLI 595.8M
- IPO Year
- TNGX N/A
- SLI N/A
- Fundamental
- Price
- TNGX $6.90
- SLI $2.83
- Analyst Decision
- TNGX Strong Buy
- SLI Buy
- Analyst Count
- TNGX 6
- SLI 2
- Target Price
- TNGX $10.00
- SLI $3.58
- AVG Volume (30 Days)
- TNGX 1.9M
- SLI 1.8M
- Earning Date
- TNGX 08-05-2025
- SLI 08-08-2025
- Dividend Yield
- TNGX N/A
- SLI N/A
- EPS Growth
- TNGX N/A
- SLI N/A
- EPS
- TNGX N/A
- SLI N/A
- Revenue
- TNGX $24,296,000.00
- SLI N/A
- Revenue This Year
- TNGX N/A
- SLI N/A
- Revenue Next Year
- TNGX N/A
- SLI N/A
- P/E Ratio
- TNGX N/A
- SLI N/A
- Revenue Growth
- TNGX N/A
- SLI N/A
- 52 Week Low
- TNGX $1.03
- SLI $1.08
- 52 Week High
- TNGX $12.02
- SLI $3.09
- Technical
- Relative Strength Index (RSI)
- TNGX 56.63
- SLI 58.76
- Support Level
- TNGX $6.60
- SLI $2.66
- Resistance Level
- TNGX $7.42
- SLI $3.09
- Average True Range (ATR)
- TNGX 0.47
- SLI 0.18
- MACD
- TNGX -0.04
- SLI -0.01
- Stochastic Oscillator
- TNGX 57.20
- SLI 59.84
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.
About SLI Standard Lithium Ltd.
Standard Lithium Corp is engaged in the exploration and development of lithium brine properties in the United States. The company is focused on the exploration and development of the Arkansas Lithium Project, which is located in south-central Arkansas. Its other projects comprise the Lanxess Project, and Bristol Dry Lake Project.